These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19910674)

  • 1. Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients.
    Ramalho AS; Lewandowska MA; Farinha CM; Mendes F; Gonçalves J; Barreto C; Harris A; Amaral MD
    Cell Physiol Biochem; 2009; 24(5-6):335-46. PubMed ID: 19910674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a large heterozygous deletion and a splicing defect in the CFTR transcripts from nasal swab of a Japanese case of cystic fibrosis.
    Nakakuki M; Fujiki K; Yamamoto A; Ko SB; Yi L; Ishiguro M; Yamaguchi M; Kondo S; Maruyama S; Yanagimoto K; Naruse S; Ishiguro H
    J Hum Genet; 2012 Jul; 57(7):427-33. PubMed ID: 22572733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation.
    Haardt M; Benharouga M; Lechardeur D; Kartner N; Lukacs GL
    J Biol Chem; 1999 Jul; 274(31):21873-7. PubMed ID: 10419506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
    Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
    J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by a 5'UTR mutation is associated with a CFTR-related disease.
    Lukowski SW; Bombieri C; Trezise AE
    Hum Mutat; 2011 Oct; 32(10):E2266-82. PubMed ID: 21837768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
    Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
    BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.
    Petrova NV; Kashirskaya NY; Saydaeva DK; Polyakov AV; Adyan TA; Simonova OI; Gorinova YV; Kondratyeva EI; Sherman VD; Novoselova OG; Vasilyeva TA; Marakhonov AV; Macek M; Ginter EK; Zinchenko RA
    BMC Med Genet; 2019 Mar; 20(1):44. PubMed ID: 30898088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.
    Sheridan MB; Hefferon TW; Wang N; Merlo C; Milla C; Borowitz D; Green ED; Mogayzel PJ; Cutting GR
    J Med Genet; 2011 Apr; 48(4):235-41. PubMed ID: 21097845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel duplication CFTRdup2 and functional impact of large rearrangements identified in the CFTR gene.
    Taulan M; Viart V; Theze C; Guittard C; Altieri JP; Templin C; Mely L; Claustres M; des Georges M
    Gene; 2012 Jun; 500(2):194-8. PubMed ID: 22484595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-frame elimination of exon 10 in Cftrtm1Unc CF mice.
    Xu Z; Gupta V; Lei D; Holmes A; Carlson E; Gruenert DC
    Gene; 1998 Apr; 211(1):117-23. PubMed ID: 9573345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-physiopathological consequences of the c.1392G>T CFTR mutation revealed by clinical and cellular investigations.
    Farhat R; El-Seedy A; El-Moussaoui K; Pasquet MC; Adolphe C; Bieth E; Languepin J; Sermet-Gaudelus I; Kitzis A; Ladevèze V
    Biochem Cell Biol; 2015 Feb; 93(1):28-37. PubMed ID: 25403292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted proteomic quantitation of the absolute expression and turnover of cystic fibrosis transmembrane conductance regulator in the apical plasma membrane.
    McShane AJ; Bajrami B; Ramos AA; Diego-Limpin PA; Farrokhi V; Coutermarsh BA; Stanton BA; Jensen T; Riordan JR; Wetmore D; Joseloff E; Yao X
    J Proteome Res; 2014 Nov; 13(11):4676-85. PubMed ID: 25227318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.
    Bednarski C; Tomczak K; Vom Hövel B; Weber WM; Cathomen T
    PLoS One; 2016; 11(8):e0161072. PubMed ID: 27526025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
    Mickle JE; Cutting GR
    Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.